Scrofula natural history, complications and prognosis: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
Line 16: | Line 16: | ||
[[Category:Tuberculosis]] | [[Category:Tuberculosis]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 18:44, 18 September 2017
Scrofula Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Scrofula natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Scrofula natural history, complications and prognosis |
FDA on Scrofula natural history, complications and prognosis |
CDC on Scrofula natural history, complications and prognosis |
Scrofula natural history, complications and prognosis in the news |
Blogs on Scrofula natural history, complications and prognosis |
Risk calculators and risk factors for Scrofula natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Prognosis
Prognosis: with adequate treatment, clinical remission is practically 100%. In NTM infections, with adequate surgical treatment, clinical remission is greater than 95%. It is recommended that persons in close contact with the diseased person, such as family members, should undergo testing for tuberculosis.